(0:10): Austria Launches DNA Tests to Combat Honey Fraud Amid Rising EU Adulteration Concerns
(2:18): ImmVira's Oncolytic Virus Shows Promise Against Aggressive Brain Cancer in Early Trials
(4:21): Revolutionary Nanotechnology Targets Triple-Negative Breast Cancer with Precision, Reducing Side Effects
(6:30): New Blood Test Outperforms Cholesterol Checks in Predicting Heart Disease Risk
(8:51): Abpro and Celltrion Reveal Promising Results for New HER2-Targeted Cancer Therapy at AACR 2025
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Yen.com.gh
View all episodes
